Virus News and Research

Latest Virus News and Research

Researchers develop way to potentially predict future infectious disease outbreaks in humans

Researchers at the University of Georgia Odum School of Ecology have developed a way to predict which species of rodents are likeliest to be sources of new disease outbreaks in humans. Their study, which includes maps showing potential future disease hot spots, appears in the Proceedings of the National Academy of Sciences.

21 May 2015

Research shows how immune system controls biological clock in times of inflammation, infection

Researchers at Trinity College Dublin and the University of Pennsylvania have uncovered an important link between our body clock and the immune system that will have relevance to the treatment of inflammatory and infectious diseases.

20 May 2015

Monash University researcher helps identify right type of Ebola vaccine trial

An Australian researcher has helped identify the kind of human trial that is most effective for testing Ebola vaccines.

20 May 2015

Study shows trophon EPR effective in inactivating high-risk, cancer-causing HPV

A new study presented at the Society for Healthcare Epidemiology of America has demonstrated that the trophon EPR is the only high level disinfection system proven to kill natural, infectious, high-risk human papilloma virus (HPV) under normal use conditions.

20 May 2015

Study shows trophon EPR effective in inactivating high-risk, cancer-causing HPV

20 May 2015

Changes in cell membrane play pivotal role in how HCV replicates

New research from the University of Southampton has identified how changes in the cell membrane play a pivotal role in how the Hepatitis C virus replicates.

20 May 2015

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and targeted drug delivery, and DNAtrix Inc., a privately held biotechnology company and a leader in oncolytic virus therapy, have entered into an exclusive clinical collaboration. Under the agreement, DNAtrix will utilize Alcyone's MEMS Cannula (AMC) targeted delivery platform for the intratumoral delivery of DNX-2401, an oncolytic adenovirus and DNAtrix's lead product for the treatment of the most aggressive form of brain cancer, glioblastoma (GBM).

19 May 2015

UTHealth receives supplemental grant to establish Biosafety and Infectious Disease Training Initiative

Researchers from The University of Texas Health Science Center at Houston School of Public Health have received a $100,000 supplemental grant from the National Institute of Environmental Health Sciences to establish a Biosafety and Infectious Disease Training Initiative.

19 May 2015

Machine learning can predict emerging infectious diseases

Machine learning can pinpoint rodent species that harbor diseases and geographic hotspots vulnerable to new parasites and pathogens. So reports a new study in the Proceedings of the National Academy of Sciences led by Barbara A. Han, a disease ecologist at the Cary Institute of Ecosystem Studies.

19 May 2015

Monash University-led researchers call for HCV patients to gain improved access to effective drugs

In a letter to the Medical Journal of Australia published today, a Monash University-led team is asking for hepatitis C virus patients to gain improved access to drugs to prevent liver related deaths.

19 May 2015

Investing in new hepatitis C therapies may have significant economic impact

While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12-week regiment, investing in these new therapies could generate savings estimated at more than $3.2 billion annually in the U.S. and five European countries, according to a new study (abstract 228) released today at Digestive Disease Week® (DDW) 2015.

18 May 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is sponsoring several data presentations on Cimzia (certolizumab pegol) at Digestive Disease Week 2015, taking place in Washington, DC from May 16-19.

17 May 2015

New genomics laboratory in Liberia enables scientists to monitor genetic changes in Ebola virus

Army scientists working to support the Ebola virus outbreak response in West Africa have established the first genomic surveillance capability in Liberia, enabling them to monitor genetic changes in the virus within one week of sample collection. An article describing their work was recently published ahead of print in the online edition of Emerging Infectious Diseases.

15 May 2015

Researchers receive NSF RAPID response grants to develop computer model for Ebola spread

Identifying and tracking individuals affected by the Ebola virus in densely populated areas presents a unique and urgent set of challenges in public health surveillance.

14 May 2015

MD Anderson researchers find significant clinical variations among liver cancer patients

Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease -hepatitis B virus (HBV) or hepatitis C virus (HCV). These differences suggest that hepatitis status should be considered when developing treatment plans for newly diagnosed patients, according to researchers at The University of Texas MD Anderson Cancer Center.

14 May 2015

ART eligibility shorter for male HIV patients in rural South Africa

Male HIV patients in rural South Africa reach the low immunity levels required to become eligible for antiretroviral treatment in less than half the time it takes for immunity levels to drop to similar levels in women, according to new research from the University of Southampton.

14 May 2015

TSRI researchers find interferon beta protein as prime suspect in persistent viral infections

Interferon proteins are normally considered virus-fighters, but scientists at The Scripps Research Institute have found evidence that one of them, interferon beta (IFNβ), has an immune-suppressing effect that can help some viruses establish persistent infections.

14 May 2015

Bronchitis can cause pneumonia, says Loyola physician

When a cold has lasted too long or a cough is especially bothersome, it's important to see a medical professional.

14 May 2015

Major breakthrough in understanding development of type 1 diabetes

Joslin researchers have uncovered the action of a gene that regulates the education of T cells, providing insight into how and why the immune system begins mistaking the body's own tissues for targets. The gene, Clec16a, is one of a suite of genes associated with multiple autoimmune disorders, suggesting it is fundamental to the development of autoimmunity.

13 May 2015

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

A simple blood test can be used to predict which chronic hepatitis C patients will respond to interferon-based therapy, according to a report in the May issue of Cellular and Molecular Gastroenterology and Hepatology, the basic science journal of the American Gastroenterological Association.

13 May 2015

Virus News and Research

Latest Virus News and Research

Researchers develop way to potentially predict future infectious disease outbreaks in humans

Research shows how immune system controls biological clock in times of inflammation, infection

Monash University researcher helps identify right type of Ebola vaccine trial

Study shows trophon EPR effective in inactivating high-risk, cancer-causing HPV

Study shows trophon EPR effective in inactivating high-risk, cancer-causing HPV

Changes in cell membrane play pivotal role in how HCV replicates

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

UTHealth receives supplemental grant to establish Biosafety and Infectious Disease Training Initiative

Machine learning can predict emerging infectious diseases

Monash University-led researchers call for HCV patients to gain improved access to effective drugs

Investing in new hepatitis C therapies may have significant economic impact

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

New genomics laboratory in Liberia enables scientists to monitor genetic changes in Ebola virus

Researchers receive NSF RAPID response grants to develop computer model for Ebola spread

MD Anderson researchers find significant clinical variations among liver cancer patients

ART eligibility shorter for male HIV patients in rural South Africa

TSRI researchers find interferon beta protein as prime suspect in persistent viral infections

Bronchitis can cause pneumonia, says Loyola physician

Major breakthrough in understanding development of type 1 diabetes

Simple blood test could help predict effectiveness of interferon-based therapy in HCV-infected patients

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in